rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

QTREX Quantum Ltd. -

QTEX · Nasdaq

Health CareMedical DevicesJust started moving

QTEX stood above a rising 150-day average in 16 of the last 52 weekly readings, including each of the last 3 weeks. It is 48.7% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
3 in a row
Industry in uptrend
29% -4 in 4 wk
Insider buys, 12 months
$301K
Insider sales, 12 months
$798K
Officials’ trades on record
0
Institutions holding
27 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

22 Apr – 21 Oct
15%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$571K$0$209KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months5
Buyers · sellers2 · 2
WhoDidSharesTraded
Tal ParnesDirectorbought6,666at $1.5015 Oct 2026filed 15 Oct 2026
Dagi Shahar Ben-NoonChief Executive Officerbought14,093at $1.4913 Oct 2026filed 13 Oct 2026
Dagi Shahar Ben-NoonChief Executive Officerbought18,181at $1.679 Oct 2026filed 9 Oct 2026
Dagi Shahar Ben-NoonChief Executive Officerbought168,894at $0.707828 Sep 2026filed 29 Sep 2026
Yafit TehilaChief Financial Officersold28,100at $3.501 Jun 2026filed 2 Jun 2026
Yafit TehilaChief Financial Officersold1,900at $3.5129 May 2026filed 2 Jun 2026
Hayon Daniella YechezkelyChief Technology Officersold50,000at $3.0029 May 2026filed 2 Jun 2026
Yafit TehilaChief Financial Officersold15,000at $2.5628 May 2026filed 29 May 2026
Yafit TehilaChief Financial Officersold15,000at $3.0028 May 2026filed 29 May 2026
Yafit TehilaChief Financial Officersold13,605at $2.0327 May 2026filed 29 May 2026
Yafit TehilaChief Financial Officersold16,395at $2.0127 May 2026filed 29 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders27+9 on the quarter
New · exited12 · 3
Reported value$3.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCnew · filed 14 Aug 20261,416,668$2.0M+1,416,668
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 2026249,061$359K+249,061
Foundations Investment Advisors, LLCnew · filed 14 Aug 2026198,000$285K+198,000
SLT Holdings LLCnew · filed 17 Jul 2026198,000$285K+198,000
JANE STREET GROUP, LLCadded · filed 14 Aug 2026141,932$204K+121,885+608.0%
Kestra Advisory Services, LLCunchanged · filed 28 Jul 202678,824$114K00.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLPreduced · filed 14 Aug 202653,452$77K-6,281−10.5%
XTX Topco Ltdadded · filed 14 Aug 202650,676$73K+429+0.9%
LPL Financial LLCnew · filed 7 Aug 202643,200$62K+43,200
Invesco Ltd.new · filed 14 Aug 202634,281$49K+34,281
31 Mar 2023 – 30 Jun 2026
31526Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Tal Parnes Company insiderDirector · last 15 Oct 20261 · 0
Dagi Shahar Ben-Noon Company insiderChief Executive Officer · last 13 Oct 20263 · 0
Lior Amit Company insiderDirector · last 28 Aug 20260 · 0
Sivan Matza Company insiderDirector · last 28 Aug 20260 · 0
abraham shabtay Company insiderCOO · last 6 Jul 20260 · 0
Hayon Daniella Yechezkely Company insiderChief Technology Officer · last 6 Jul 20260 · 1
Yafit Tehila Company insiderChief Financial Officer · last 6 Jul 20260 · 4
Yoav Rozanovich Company insiderChief Business Officer · last 6 Jul 20260 · 0

Same industry

RCEL Avita MedicalLeading+127%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+51%
HAE HaemoneticsLeading+44%
BVS BioventusLeading+24%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 20250.7%
Share count trendFY 2025 · to 31 Dec 202548.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$3.2M
Free cash flowFY 2025 · to 31 Dec 2025−$10.0M

Analyst forecasts

No analyst forecasts yet.